Equity Details
Price & Market Data
Price: $0.0198
Daily Change: -$0.0₃25 / 1.27%
Daily Range: $0.0185 - $0.021
Market Cap: $8,495,685
Daily Volume: 404,981
Performance Metrics
1 Week: -12.95%
1 Month: -26.35%
3 Months: 162.3%
6 Months: 199.2%
1 Year: -12.95%
YTD: 118.9%
About Revive Therapeutics Ltd. (RVVTF)
Dive into the market stats for Revive Therapeutics Ltd. (RVVTF). Current price: 0.0198, daily change: -$0.0₃25 / 1.27%. Market cap: 8,495,685. All essential performance metrics are provided.
Details
Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It develops Bucillamine, a disease-modifying anti-rheumatic drug, for the treatment of infectious diseases, including influenza and COVID-19, as well as to treat pandemic influenza, emerging infectious diseases, and medical countermeasure incidents and attacks. The company also develops Psilocybin, which is in Phase 1 clinical study for treating methamphetamine use disorder; and Psilocin for the treatment of depression, anxiety, bi-polar disorder, bulimia and anorexia nervosa, and other diseases. Revive Therapeutics Ltd. is based in Toronto, Canada.